• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

neuroimaging

  1. C

    Johns Hopkins neuroimaging study reveals functional and structural brain abnormalities in people with post-treatment Lyme disease - Eurekalert, 2022

    In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the “white matter” and other brain tissue physiology of those with post-treatment Lyme disease, a condition affecting 10% to 20% of the nearly half a million Americans who contract...
  2. Phoenix Rising Articles

    Article Scientific Findings Distinguish Between Myalgic Encephalomyelitis and Chronic Fatigue Syndrome

    Scientific Findings Distinguish Between Myalgic Encephalomyelitis and Chronic Fatigue Syndrome Dr. Kiran Thapaliya and colleagues used an advanced form of medical imaging to spot significant abnormalities in the brainstem of patients diagnosed with myalgic encephalomyelitis. However, no...
  3. nerd

    Review: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?

    Authors: Iñigo Murga Gandasegui, Larraitz Aranburu Laka, Pascual-Ángel Gargiulo, Juan-Carlos Gómez-Esteban, José-Vicente Lafuente Sánchez Published: 27 September 2021 doi: 10.3390/medicina57101030 Abstract
  4. leokitten

    Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders (2019) Werry et al

    An interesting read given the past TSPO-PET neuroinflammation studies on ME using first generation [11C]PK-11195 and now more recently second generation [11C]DPA-713, the pros/cons and limitations of these radioligands, and the development of novel third generation ligands. Recent Developments...